Excessive fibrin deposition in nasal polyps caused by fibrinolytic impairment through reduction of tissue plasminogen activator expression.
about
Aspirin-exacerbated respiratory disease: pathophysiological insights and clinical advancesChronic Rhinosinusitis and the Coagulation SystemUpdate in asthma 2013Emerging Endotypes of Chronic Rhinosinusitis and Its Application to Precision Medicine.Immunopathogenesis of Chronic Rhinosinusitis and Nasal Polyposis.ICON: chronic rhinosinusitis.The development of nasal polyp disease involves early nasal mucosal inflammation and remodelling.Biology of nasal polyposis.Pathogenesis of nasal polyposisChronic rhinosinusitis pathogenesis.Oncostatin M promotes mucosal epithelial barrier dysfunction, and its expression is increased in patients with eosinophilic mucosal diseaseCytokines in Chronic Rhinosinusitis. Role in Eosinophilia and Aspirin-exacerbated Respiratory Disease.Genetics of chronic rhinosinusitis: state of the field and directions forwardIncreased expression of factor XIII-A in patients with chronic rhinosinusitis with nasal polyps.Novel scoring system and algorithm for classifying chronic rhinosinusitis: the JESREC Study.Immunophenotyping and protein profiling of Fontan-associated plastic bronchitis airway castsImmunopathology of chronic rhinosinusitis.Remodeling and Repair in Rhinosinusitis.Regulation of airway inflammation by Siglec-8 and Siglec-9 sialoglycan ligand expression.Classification of chronic rhinosinusitis according to a nasal polyp and tissue eosinophilia: limitation of current classification system for Asian population.Antifibrinolytic mechanisms in acute airway injury after sulfur mustard analog inhalationPotential Involvement of the Epidermal Growth Factor Receptor Ligand Epiregulin and Matrix Metalloproteinase-1 in Pathogenesis of Chronic Rhinosinusitis.Allergic Aspergillus Rhinosinusitis.Short chain fatty acids induce tissue plasminogen activator in airway epithelial cells via GPR41&43.Cellular comparison of sinus mucosa vs polyp tissue from a single sinus cavity in chronic rhinosinusitis.Proprotein convertases generate a highly functional heterodimeric form of thymic stromal lymphopoietin in humans.Activation of group 2 innate lymphoid cells exacerbates and confers corticosteroid resistance to mouse nasal type 2 inflammation.Interference With Coagulation Cascade as a Novel Approach to Counteract Cisplatin-Induced Acute Tubular Necrosis; an Experimental Study in Rats
P2860
Q26750424-39C29054-7CB3-4C29-8A7F-696ED84FF46EQ26851357-B7BB8F16-4A31-4F28-9B5E-DF3A898F2038Q33732168-E930DCF1-57F3-4864-88B3-390EEFF8A1C1Q33734329-49087D5E-48AB-4B25-96F0-FA19DD798B1DQ33913202-5CC524DC-D8A8-4230-AB9A-F135CF1880A2Q34423484-6BF4257E-6326-4B88-9EFD-C09B8FFEC51FQ35067772-A98AF3B1-F9E5-48F2-8AC0-E961AFBC1D02Q35576575-B0D5D6CC-D9AC-4C64-BF5E-C8192657C1C2Q35576619-E6A0DD8A-B3F0-4B53-817F-C13036B9DC34Q35865515-C49DF84C-9283-49F4-B3AB-5DD0D9DC56B2Q36037454-0043F78C-852A-402C-B132-E9B111BFC21FQ36128536-E516DBF0-6C73-4BD2-A095-C35AE988050AQ37026149-7CE76EEC-71BC-4ED6-9A8F-9C29DB39FA72Q37080005-63B8200B-F84D-46F0-B577-BFF7E977128DQ37275557-06833EC4-2232-4934-B9D3-70D1694A88EEQ37651516-6AD10CEA-C8A0-4E3C-A081-D9AEA1275680Q38403174-01D178DB-34A6-434F-BA7A-DE3665804663Q38542580-69B6F9E7-BE06-499C-A6B6-F6200777E497Q38676224-ADC32D8C-319E-4F6E-A809-8BF6F2ECE7BAQ41190514-56DF412A-8A18-4341-B869-62E119B54D96Q42057115-1565848F-94EE-420B-88AA-6EF3AA71740CQ47923013-867C4BA3-A4E1-4A1D-908A-34E3BAD5A4CDQ48152629-20264EB2-B258-490D-A547-651BCAE4FF7EQ50065287-A0D56940-2273-418C-80A9-983457F722A8Q51105848-C2F4F631-C584-4D8E-B853-9C024770FF00Q51390977-2D9EA443-FFFE-4607-A1E2-90E1AEB29E1DQ53738990-CF141996-76DA-4F03-B03C-6672C5633488Q58573275-1EB499CE-5EB6-429A-A2DC-CB8C7EA3419E
P2860
Excessive fibrin deposition in nasal polyps caused by fibrinolytic impairment through reduction of tissue plasminogen activator expression.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Excessive fibrin deposition in ...... sminogen activator expression.
@ast
Excessive fibrin deposition in ...... sminogen activator expression.
@en
type
label
Excessive fibrin deposition in ...... sminogen activator expression.
@ast
Excessive fibrin deposition in ...... sminogen activator expression.
@en
prefLabel
Excessive fibrin deposition in ...... sminogen activator expression.
@ast
Excessive fibrin deposition in ...... sminogen activator expression.
@en
P2093
P2860
P50
P1476
Excessive fibrin deposition in ...... sminogen activator expression.
@en
P2093
Anju T Peters
Bruce K Tan
David B Conley
James Norton
Lydia A Suh
Rakesh K Chandra
Robert P Schleimer
Roderick Carter
Seong H Cho
Shigeharu Fujieda
P2860
P356
10.1164/RCCM.201207-1292OC
P407
P577
2012-11-15T00:00:00Z